N-(3,5-bis(trifluoromethyl)phenyl)isoquinoline-1-carboxamide

ID: ALA4857384

PubChem CID: 164612448

Max Phase: Preclinical

Molecular Formula: C18H10F6N2O

Molecular Weight: 384.28

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1nccc2ccccc12

Standard InChI:  InChI=1S/C18H10F6N2O/c19-17(20,21)11-7-12(18(22,23)24)9-13(8-11)26-16(27)15-14-4-2-1-3-10(14)5-6-25-15/h1-9H,(H,26,27)

Standard InChI Key:  FWHCIQRQIUXGRR-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 29  0  0  0  0  0  0  0  0999 V2000
   16.0879  -14.6847    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.6835  -13.9789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.2745  -14.6821    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   19.0967  -13.3846    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   18.5189  -13.9665    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3118  -14.1760    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   15.6820   -9.0840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6809   -9.9035    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3890  -10.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3872   -8.6751    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0958   -9.0804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0965   -9.8994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8051  -10.3065    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5133   -9.8957    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5086   -9.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.7995   -8.6702    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8068  -11.1237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0999  -11.5337    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.5153  -11.5308    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   17.1016  -12.3509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3931  -12.7558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3945  -13.5723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1036  -13.9802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8128  -13.5658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8079  -12.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5273  -14.7876    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.9791  -13.5745    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  5  4  1  0
  6  5  1  0
  7  8  2  0
  8  9  1  0
  9 12  2  0
 11 10  2  0
 10  7  1  0
 11 12  1  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 13 17  1  0
 17 18  1  0
 17 19  2  0
 18 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 24  5  1  0
  5 26  1  0
 22  2  1  0
  2 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4857384

    ---

Associated Targets(Human)

NUGC-3 (976 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 384.28Molecular Weight (Monoisotopic): 384.0697AlogP: 5.52#Rotatable Bonds: 2
Polar Surface Area: 41.99Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 0.88CX LogP: 4.98CX LogD: 4.98
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.59Np Likeness Score: -1.23

References

1. Sim S, Lee S, Ko S, Phuong Bui B, Linh Nguyen P, Cho J, Lee K, Kang JS, Jung JK, Lee H..  (2021)  Design, synthesis, and biological evaluation of potent 1,2,3,4-tetrahydroisoquinoline derivatives as anticancer agents targeting NF-κB signaling pathway.,  46  [PMID:34500188] [10.1016/j.bmc.2021.116371]

Source